0001209191-22-017345.txt : 20220308 0001209191-22-017345.hdr.sgml : 20220308 20220308200130 ACCESSION NUMBER: 0001209191-22-017345 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220304 FILED AS OF DATE: 20220308 DATE AS OF CHANGE: 20220308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ciambrone William CENTRAL INDEX KEY: 0001794135 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 22723501 MAIL ADDRESS: STREET 1: 215 FIRST ST STREET 2: SUIT 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-04 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001794135 Ciambrone William 215 FIRST STREET, SUITE 415 CAMBRIDGE MA 02142 0 1 0 0 EVP Common Stock 2022-03-04 4 F 0 1160 79.20 D 14099 D Common Stock 2022-03-07 4 A 0 8000 0.00 A 22099 D Stock Option (right to buy) 80.42 2022-03-07 4 A 0 48000 0.00 A 2023-03-07 2032-03-07 Common Stock 48000 48000 D Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021. The amount of securities directly owned by the reporting person includes the following shares of common stock purchased under the Company's Amended and Restated 2013 Employee Stock Purchase Plan: 77 shares on February 28, 2022, 75 shares on August 31, 2021, 62 shares on February 28, 2021 and 45 shares on August 31, 2020. The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date. Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter. /s/ Ryan Brown, as Attorney-in-Fact for William Ciambrone 2022-03-08